Amended Statement of Beneficial Ownership (sc 13d/a)
21 June 2021 - 8:32PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D/A
Under the Securities Exchange Act of 1934
(Amendment No. 2)
|
OWC Pharmaceutical Research Corp.
|
|
(Name of Issuer)
|
|
Common Stock
|
|
(Title of Class of Securities)
|
Discover Growth Fund, LLC
5330 Yacht Haven Grande, Suite 206
St. Thomas, VI 00802
Attn: John Kirkland
|
(340) 774-8800
|
|
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
|
|
June 17, 2021
|
|
(Date of Event Which Requires Filing of this Statement)
|
If the filing
person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing
this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box ☐.
|
|
*
|
The remainder of this cover page shall be filled out for
a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment
containing information which would alter the disclosures provided in a prior cover page.
|
The information required in the remainder of this
cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”)
or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
CUSIP No. 26784V108
1. Names
of Reporting Person: DISCOVER GROWTH FUND, LLC
I.R.S. Identification Nos. of above persons (entities only): 66-0854607
2. Check
the Appropriate Box if a Member of a Group (See Instructions)
3. SEC Use Only:
4. Source
of Funds (See Instruction): WC
5. Check
if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or (e): ☐
6. Citizenship
or Place of Organization: U.S. Virgin Islands
Number of Shares Beneficially by Owned by Each Reporting Person
With:
|
7
|
Sole Voting Power:
|
55,493,834
|
|
|
|
|
|
8
|
Shared Voting Power:
|
0
|
|
|
|
|
|
9
|
Sole Dispositive Power:
|
55,493,834
|
|
|
|
|
|
10
|
Shared Dispositive Power:
|
0
|
11. Aggregate
Amount Beneficially Owned by Each Reporting Person: 55,493,834
12.
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions): ☐
13. Percent
of Class Represented by Amount in Row (11): 9.990%
14. Type of
Reporting Person (See Instructions): OO
ITEM 4. PURPOSE
OF TRANSACTION
The Reporting Person holds no shares of the Issuer’s Common Stock.
The Reporting person holds 366 shares of Series A Preferred Stock
On June 17, 2021, the Reporting Person entered into an agreement with
the Issuer provides that the Issuer shall not affect the conversion of any of the Preferred Shares to the extent that after giving effect
to such conversion, the Reporting Person and all other attribution parties would beneficially own in excess of 4.99% of the shares of
Common Stock outstanding immediately after giving effect to such conversion, which provision may be may be increased up to but not in
excess of 9.99% by written notice to the Issuer, which notice shall be effective sixty-one (61) calendar days after the date of such notice.
The Reporting Person now intends to resume its status as a passive
investor.
ITEM 5. INTEREST
IN SECURITIES OF THE ISSUER
|
|
(a)
|
See rows (11) and (13) of the cover pages to this Schedule
13D for the aggregate number of and percentages of the shares of Common Stock beneficially owned by the Reporting Person. The percentages
set forth in this Schedule 13D are based upon 500,000,000 shares of Common Stock outstanding.
|
|
|
(b)
|
See rows (7) through (10) of the cover pages to this Schedule
13D for the number of shares of Common Stock as to which each Reporting Person has the sole or shared power to vote or direct the vote
and sole or shared power to dispose or to direct the disposition.
|
|
|
(c)
|
No transactions in the shares of Common Stock of the Issuer
have been effected by the Reporting Person during the past sixty (60) days.
|
|
|
(d)
|
No person (other than the Reporting Person) is known to have
the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock
of the Issuer.
|
ITEM 6. CONTRACTS,
ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER
See Item 4 which is incorporated herein by reference.
SIGNATURE
After reasonable inquiry and to the best of my
knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
Dated: June 18, 2021
|
DISCOVER GROWTH FUND, LLC
|
|
|
|
|
|
/s/ John Kirkland
|
|
|
Name:
|
John Kirkland, President of G.P. of Member
|
4
OWC Pharmaceuticals Rese... (CE) (USOTC:OWCP)
Historical Stock Chart
From Nov 2024 to Dec 2024
OWC Pharmaceuticals Rese... (CE) (USOTC:OWCP)
Historical Stock Chart
From Dec 2023 to Dec 2024
